Study finds e-cigarette users may unknowingly fail sobriety tests

Sep.09.2022
Study finds e-cigarette users may unknowingly fail sobriety tests
Researchers found that vaping with e-liquids containing 20% ethanol can impact initial breathalyzer tests but waiting 15-20 minutes before testing should provide an accurate reading.

Five years ago, researchers led by Dr. Michelle Peace, a forensic science professor at Virginia Commonwealth University, revealed that electronic cigarette liquids - the flavored nicotine solutions used in e-cigarettes - often contain ethanol or alcohol as an undisclosed ingredient.


The presence of ethanol in e-cigarette liquid raises an important concern for public safety and law enforcement: can inadvertently consuming alcohol through vaping cause a sober individual to fail a breathalyzer test?


To answer this question, Peace and Dr. Alison Breland, Chief Research Officer at United Health, teamed up with a professor from the College of Humanities and Sciences' psychology department and the VCU Tobacco Products Research Center to conduct a human clinical study, in collaboration with the Virginia Department of Forensic Science and the VCU Police Department.


Researchers had 13 participants use e-cigarette oils with either 20% ethanol or 0% ethanol concentrations. Prior to and after vaping, Lieutenant Edgar Greer from the VCU Police Department conducted preliminary and evidential breath tests, as well as standardized field sobriety tests - including horizontal gaze nystagmus (HGN), walk-and-turn, and one-leg stand - to replicate roadside procedures used by law enforcement in suspected DUI cases.


They discovered that after inhaling e-liquid containing 20% ethanol, a preliminary breath test can immediately (in less than a minute) detect the concentration of exhaled ethanol.


However, when the police waited the standard 15 to 20 minutes (waiting time for roadside breath testing) the individual had consumed electronic cigarette oil containing 20% ethanol, as predicted, resulting in an inconclusive preliminary breath test. Researchers also found that consuming ethanol did not affect standardized field sobriety testing, evidence that breath testing is completely unaffected by ethanol consumption.


We have reported negative results, and we are very excited about this," said Peace. "During our study, we found that a waiting time of 15 to 20 minutes was consistent. We need to include this in the literature because some lawyers are trying to use e-cigarette use as a defense for avoiding driving under the influence charges. What we can now say is that if a state or jurisdiction maintains a 15 to 20 minute waiting period, e-cigarette use will not affect preliminary breath tests.


Wait for 15 to 20 minutes to allow the ethanol to be reabsorbed and disappear from the mouth. The waiting period is crucial because e-cigarette liquid is sticky and often stays in the mouth shortly after use. We are concerned that the sticky nature may make it more difficult for ethanol to disappear from the mouth," said Peace.


The researchers' findings will have an impact beyond law enforcement. Alaina Holt, a doctoral student in the VCU Integrated Life Sciences program who worked with Peace, explained that these discoveries should be taken into consideration in other contexts of alcohol testing, including workplace screening test sites.


According to Holt, some institutions and industries use preliminary breath testing devices to indicate alcohol consumption. If they are not within a waiting period of 5 to 20 minutes, in this situation, individuals who continuously vape may test positive.


The results of this research will be presented at the annual meeting of the International Association of Forensic Toxicologists in France this week. The study was funded by the National Institute of Justice, a branch of the US Department of Justice, for a project called "Vaping Ethanol on DUI: Investigating the Effects.


In 2018 and 2019, the National Institute of Justice provided two grants totaling approximately $1.8 million to Peace and her collaborators for research on the effects of consuming ethanol.


These experiments are being conducted at the Tobacco Product Research Center, which brings together multidisciplinary faculty from VCU, the American University of Beirut, Johns Hopkins University, the University of Arkansas for Medical Sciences, the Oklahoma Health Sciences Center, the University of Southern California, as well as other American and international universities and organizations focused on regulating tobacco products.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's contents. The compilation of this article is solely for communication and research within the industry.


Due to limitations in translation proficiency, the translated article may not fully express the same meaning as the original text. Please refer to the original text for accuracy.


2FIRSTS is fully aligned with the Chinese government's positions and statements on any domestic, Hong Kong, Macao, Taiwan, or foreign-related issues.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
Why Does JPMorgan Favor BAT Over Philip Morris Despite Forecasting Slower Growth of 3.9% Versus 6.2%?
JPMorgan resumed equity research coverage of British American Tobacco (BAT), Philip Morris International (PMI) and Imperial Brands in November 2026, assigning BAT an Overweight rating and the other two companies Neutral ratings. The bank forecasts like-for-like sales growth of 3.9% for BAT and 6.2% for PMI in 2027, but estimates the two companies will trade at approximately 11 times and 21 times 2027 earnings, respectively. JPMorgan cited BAT's improving position in US nicotine pouches and vaping products as a driver of its investment outlook. BAT reported a 220% constant-currency increase in US modern oral nicotine revenue in the first half of 2026, while PMI's ZYN US shipments returned to growth in the third quarter. Imperial expects NGPs to represent 4% to 5% of sales and has expanded its oral portfolio through acquisitions.
Capital Markets
Nov.12
Russia Expands Temporary Administration of JTI Assets in Second Round: From Four to All Seven Russian Entities, With Approximately $9.5 Billion in Related Assets
Russia Expands Temporary Administration of JTI Assets in Second Round: From Four to All Seven Russian Entities, With Approximately $9.5 Billion in Related Assets
Japan Tobacco Inc. (JT) confirmed on November 9, 2026, that all seven of its Russian entities had been placed under temporary administration after a second presidential decree added three companies to the four designated a day earlier. The additional entities are associated with importing, management, holdings and the former supply of Ploom heated-tobacco devices. JT disclosed approximately ¥1.5 trillion in Russian business-related assets as of September 30, including ¥360 billion in cash and deposits, and approximately ¥200 billion in liabilities. Under its revised FY2026 forecast, Russia accounts for about 25% of adjusted operating profit. JT said operations in Russia were continuing, while the financial impact remained under assessment.
company
Nov.09
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Krishnamoorthi Questions FDA Over Planned PMTA Rewrite, Seeks Communications With Altria and Reynolds
U.S. Rep. Raja Krishnamoorthi on Oct. 6 questioned the FDA over its plan to reassess and potentially replace the 2021 PMTA regulatory framework, asking the agency to identify provisions it may change or eliminate, state whether current scientific evidentiary standards will be maintained, and disclose communications with Altria, Reynolds and other parties challenging the rule. Krishnamoorthi led a congressional investigation into JUUL and youth vaping in 2019 and has since remained active on e-cigarette regulation and enforcement.
Regulations
Oct.08
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22